Stock Research: Bayer

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

Bayer

XTRA:BAYN DE000BAY0017
10
  • Value
    20
  • Growth
    19
  • Safety
    Safety
    93
  • Combined
    31
  • Sentiment
    9
  • 360° View
    360° View
    10
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Bayer AG is a life science company focusing on crop science, pharmaceuticals, and consumer health. It operates in the crop science, pharmaceuticals, and consumer health industries. In the last fiscal year, the company had a market cap of $31,052 million, profits of $26,230 million, revenue of $48,251 million, and 92,815 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 10 (better than 10% compared with alternatives), overall professional sentiment and financial characteristics for the stock Bayer are critical, mostly below average. The 360° View is based on consolidating four consolidated indicators, with three out of four indicators below average for Bayer. Only the consolidated Value Rank has an attractive rank of 93, which means that the share price of Bayer is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means that the stock price is lower than for 93% of alternative stocks in the same industry. All other consolidated ranks are below average. The consolidated Growth Rank has a low rank of 19, which means that the company exhibits below-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. The consolidated Safety Rank has a riskier rank of 20, meaning the company has a riskier financing structure than 80% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. Finally, professionals are more pessimistic about the stock than for 91% of alternative investment opportunities, reflected in the consolidated Sentiment Rank of 9. ...read more

more
Index
CDAX
DAX 40
EURO STOXX 50
Dividends Europe
Employee Focus EU
Diversity Europe
Human Rights
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 21-Aug-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
93 96 99 92
Growth
19 4 5 33
Safety
Safety
20 39 16 6
Sentiment
9 1 1 4
360° View
360° View
10 14 1 12
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
15 3 34 55
Opinions Change
86 50 10 40
Pro Holdings
n/a 19 1 26
Market Pulse
14 19 9 9
Sentiment
9 1 1 4
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
93 96 99 92
Growth
19 4 5 33
Safety Safety
20 39 16 6
Combined
31 44 16 29
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
100 100 97 93
Price vs. Earnings (P/E)
97 97 86 75
Price vs. Book (P/B)
95 97 88 67
Dividend Yield
26 29 92 88
Value
93 96 99 92
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
6 10 19 42
Profit Growth
29 12 25 14
Capital Growth
45 34 42 77
Stock Returns
51 16 14 44
Growth
19 4 5 33
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
12 12 14 6
Refinancing
61 82 49 33
Liquidity
19 43 31 25
Safety Safety
20 39 16 6

Similar Stocks

Discover high‑ranked alternatives to Bayer and broaden your portfolio horizons.

thyssenkrupp

XTRA:TKA
Country: Germany
Industry: Steel
Size: X-Large
Full Stock Analysis

KSB

XTRA:KSB
Country: Germany
Industry: Industrial Machinery
Size: Medium
Full Stock Analysis

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt.

BUSE:RICHTER
Country: Hungary
Industry: Pharmaceuticals
Size: Medium
Full Stock Analysis

Infineon

XTRA:IFX
Country: Germany
Industry: Semiconductors
Size: X-Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.